Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Qu, Mingyuea; * | Shi, Hanxua | Wang, Kaia | Wang, Xinggangb | Yu, Nana | Guo, Baoshia; *
Affiliations: [a] The PLA Rocket Force Characteristic Medical Center, Beijing, China | [b] Zibo Prevention and Treatment Center for Occupational Diseases (Affiliated Hospital of Jining Medical College), Shandong, China
Correspondence: [*] Correspondence to: Mingyue Qu, The PLA Rocket Force Characteristic Medical Center, Beijing, 100088, China. Tel.: +86 10 66343294; Fax: +86 10 66343294; E-mail: [email protected] and Baoshi Guo, The PLA Rocket Force Characteristic Medical Center, Beijing, 100088, China. Tel.: +86 10 62467079; Fax: +86 10 62467079; E-mail: [email protected].
Abstract: Background:Multiple lines of evidence indicate protective effects of carotenoids in Alzheimer’s disease (AD). However, previous epidemiological studies reported inconsistent results regarding the associations between carotenoids levels and the risk of AD. Objective:Our study aims to evaluate the associations of six major members of carotenoids with the occurrence of AD by conducting a systematic review and meta-analysis. Methods:Following PRISMA guidelines, a comprehensive literature search of PubMed, Web of Science, Ebsco, and PsycINFO databases was conducted, and the quality of each included studies was evaluated by a validated scoring systems. Standardized mean differences (SMD) with 95% confidence intervals (CI) were determined by using a random effects model. Heterogeneity was evaluated by I2 statistics. Publication bias was detected using funnel plots and Egger’s test. Results:Sixteen studies, with 10,633 participants were included. Pooled analysis showed significantly lower plasma/serum levels of lutein (SMD = –0.86, 95% CI: –1.67 to –0.05, p = 0.04) and zeaxanthin (SMD = –0.59; 95% CI: –1.12 to –0.06, p = 0.03) in patients with AD versus cognitively intact controls, while α-carotene (SMD = 0.21, 95% CI: –0.68 to 0.26, p = 0.39), β-carotene (SMD = 0.04, 95% CI: –0.57 to 0.65, p = 0.9), lycopene (SMD = –0.12, 95% CI: –0.96 to 0.72, p = 0.78), and β-cryptoxanthin (SMD = –0.09, 95% CI: –0.83 to 0.65, p = 0.81) did not achieve significant differences. Conclusion:Of six major members of carotenoids, only lutein and zeaxanthin concentrations in plasma/serum were inversely related to the risk of AD. More high-quality longitudinal studies are needed to verify these findings.
Keywords: Alzheimer’s disease, carotenes, carotenoids, xanthophylls
DOI: 10.3233/JAD-210384
Journal: Journal of Alzheimer's Disease, vol. 82, no. 3, pp. 1055-1066, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]